title: Excitatory modulation in the cochlear nucleus through group I metabotropic glutamate receptor activation.
abstract: Activation of group I metabotropic glutamate receptors (mGluRs) has been suggested to modulate development of auditory neurons. However, the acute effects of mGluR activation on physiological response properties are unclear. To address this, we studied the effects of mGluRs in bushy cells (BCs) of the mammalian anteroventral cochlear nucleus (AVCN). Activation of mGluRs with dihydroxyphenylglycine (DHPG) caused depolarization of BCs in mice as old as P42, but did not affect neurotransmitter release by presynaptic auditory nerve (AN) fibers. Application of mGluR antagonists indicated that mGluRs are tonically active, and are highly sensitive to small elevations in ambient glutamate by the glutamate reuptake blocker threo-β-benzyloxyaspartic acid (TBOA). mGluR-mediated depolarization enhanced the firing probability in response to AN stimulation, and reduced the latency and jitter. Furthermore, excitation through postsynaptic mGluRs can significantly counterbalance the inhibitory effects of presynaptic GABA(B) receptors. Thus, interaction between these two modulatory pathways may provide additional flexibility for fine-tuning the BC relay.
authors: Department of Biological Sciences, University at Buffalo, State University of New York, Buffalo, New York 14260, USA.
authors: Soham
authors: S
authors: Chanda
authors: Matthew A
authors: MA
authors: Xu-Friedman
references: J Neurosci. 2002 Dec 15;22(24):11004-18
references: 12486196
references: J Physiol. 2002 Apr 15;540(Pt 2):447-55
references: 11956335
references: Nat Neurosci. 2003 Oct;6(10):1048-57
references: 14502290
references: Brain Res. 1986 Sep 10;382(1):174-7
references: 2876750
references: J Neurophysiol. 2008 May;99(5):2510-21
references: 18367696
references: Physiol Rev. 2010 Jul;90(3):983-1012
references: 20664077
references: J Neurosci. 2004 Jun 30;24(26):5955-65
references: 15229243
references: J Neurophysiol. 2010 Oct;104(4):2063-74
references: 20702743
references: J Neurophysiol. 2008 Sep;100(3):1255-64
references: 18632895
references: Nature. 1981 Mar 12;290(5802):149-52
references: 6259535
references: Mol Pharmacol. 1998 Feb;53(2):195-201
references: 9463476
references: J Neurosci. 2001 Dec 15;21(24):RC188
references: 11734603
references: Neuron. 2008 Nov 26;60(4):642-56
references: 19038221
references: Mol Pharmacol. 1999 Mar;55(3):453-61
references: 10051528
references: Pharmacol Rev. 2008 Dec;60(4):536-81
references: 19112153
references: J Neurophysiol. 2010 Apr;103(4):1915-26
references: 20107122
references: Eur J Neurosci. 1998 Nov;10(11):3438-50
references: 9824457
references: J Neurosci. 1983 Oct;3(10):2043-53
references: 6619923
references: Eur J Pharmacol. 1993 Apr 22;235(1):153-5
references: 8390938
references: J Neurophysiol. 2008 Mar;99(3):1077-95
references: 18199821
references: Neuropharmacology. 1999 Oct;38(10):1493-503
references: 10530811
references: Neuroreport. 1992 Nov;3(11):1013-6
references: 1362358
references: Hear Res. 2010 Aug;267(1-2):46-53
references: 20430074
references: Brain Res Brain Res Rev. 1999 Jan;29(1):83-120
references: 9974152
references: J Neurophysiol. 1994 Nov;72(5):2124-33
references: 7884448
references: J Assoc Res Otolaryngol. 2000 Sep;1(2):103-19
references: 11545139
references: J Neurosci. 1986 Sep;6(9):2691-706
references: 3746428
references: J Neurophysiol. 1996 Dec;76(6):4127-39
references: 8985906
references: Science. 1990 Feb 2;247(4942):571-4
references: 2154034
references: J Comp Neurol. 1975 Apr 15;160(4):491-506
references: 1091667
references: J Neurophysiol. 2007 May;97(5):3365-75
references: 17376850
references: Neuron. 2001 Aug 16;31(3):463-75
references: 11516402
references: J Neurosci. 2010 Sep 8;30(36):12075-83
references: 20826670